DNA surface modified gadolinium phosphate nanoparticles as MRI contrast agents

Bioconjugate Chemistry

Volumn 23, Issue 5, 2012, Pages 951-957

  Dumont, Matthieu F ^a   Baligand, Celine ^b   Li, Yichen ^a   Knowles, Elisabeth S ^a   Meisel, Mark W ^a   Walter, Glenn A ^b   Talham, Daniel R ^a  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNETIC RESONANCE; MICROEMULSIONS; NANOMAGNETICS; NANOPARTICLES; OLIGONUCLEOTIDES; SURFACE TREATMENT; SYNTHESIS (CHEMICAL);

CONTRAST AGENT; DNA SURFACE; MRI CONTRAST AGENTS; PROPERTY; RELAXIVITY; SURFACE-MODIFICATION; SURFACE-MODIFIED; SYNTHESISED; WATER/OIL MICROEMULSION; ZIRCONIUM PHOSPHONATE;

GADOLINIUM COMPOUNDS;

AGAROSE; DNA; GADODIAMIDE; GADOLINIUM; GADOLINIUM PHOSPHATE NANOPARTICLE; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; OLIGONUCLEOTIDE; SUPERPARAMAGNETIC IRON OXIDE; SURFACTANT; UNCLASSIFIED DRUG; ZIRCONIUM DERIVATIVE;

ARTICLE; DRUG SYNTHESIS; MEASUREMENT; MICROEMULSION; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; SURFACE PROPERTY; SYNTHESIS; X RAY DIFFRACTION;

CONTRAST MEDIA; DNA; GADOLINIUM; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; OLIGONUCLEOTIDES; PHOSPHATES; SURFACE PROPERTIES;

EID: 84861174132     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200553h     Document Type: Article

References (33)

1. Fukumori, Y. and Ichikawa, H. (2006) Nanoparticles for cancer therapy and diagnosis Adv. Powder Technol. 17, 28-33
2. Louie, A. (2010) Multimodality imaging probes: design and challenges Chem. Rev. 110, 3146-3171
3. Oghabian, M. A. and Farahbakhsh, N. M. (2010) Potential use of nanoparticle based contrast agents in MRI: a molecular imaging perspective J. Biomed. Nanotechnol. 6, 203-207
4. Cahill, K. S., Germain, S., Byrne, B. J., and Walter, G. A. (2004) Non-invasive analysis of myoblast transplants in rodent cardiac muscle Int. J. Cardiovasc. Imaging 20, 593-597
5. Caravan, P., Ellison, J. J., McMurry, T. J., and Lauffer, R. B. (1999) Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications Chem. Rev. 99, 2293-2321
6. Sharma, P., Brown, S., Walter, G., Santra, S., and Moudgil, B. (2006) Nanoparticles for bioimaging Adv. Colloid Interface Sci. 123, 471-476
7. Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., and Muller, R. N. (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications Chem. Rev. 108, 2064-2069
8. Boyd, A. S., Zic, J. A., and Abraham, J. L. (2007) Gadolinium deposition in nephrogenic fibrosing dermopathy J. Am. Acad. Dermatol. 56, 27-31
9. DaSilva, M., Deming, M. O., Fligiel, S. E. G., Dame, M. K., Johnson, K. J., Swartz, R. D., and Varani, J. (2010) Responses of human skin in organ culture and human skin fibroblasts to a gadolinium-based MRI contrast agent comparison of skin from patients with end-stage renal disease and skin from healthy subjects Invest. Radiol. 45, 733-737
10. Ersoy, H. and Rybicki, F. J. (2007) Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis J. Magn. Reson. Im. 26, 1190-1194
11. Thakral, C. and Abraham, J. L. (2009) Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis J. Cutananeous Pathol. 36, 1244-1248
12. Bridot, J.-L., Faure, A.-C., Laurent, S., Riviere, C., Billotey, C., Hiba, B., Janier, M., Josserand, V., Coll, J.-L., Vander Elst, L., Muller, R., Roux, S., Perriat, P., and Tillement, O. (2007) Hybrid gadolinium oxide nanoparticles: a multimodal contrast agents for in vivo imaging J. Am. Chem. Soc. 129, 5076-5081
13. McDonald, M. A. and Watkin, K. L. (2006) Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles Acad. Radiol. 13, 421-426
14. Park, J. Y., Baek, M. J., Choi, E. S., Woo, S., Kim, J. H., Kim, T. J., Jung, J. C., Chae, K. S., Chang, Y., and Lee, G. H. (2009) Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1MR images ACS Nano 3, 3663-3668
15. Cheung, E. N., Alvares, R. D. A., Oakden, W., Chaudhary, R., Hill, M. L., Pichaandi, J., Mo, G. C. H., Yip, C., Macdonald, P. M., Stanisz, G. J., van Veggel, F. C., and Prosser, R. S. (2010) Polymer-stabilized lanthanide fluoride nanoparticle aggregates as contrast agents for magnetic resonance imaging and computed tomography Chem. Mater. 22, 4728-4733
16. Gerion, D., Herberg, J., Bok, R., Gjersing, E., Ramon, E., Maxwell, R., Kurhanewicz, J., Budinger, T. F., Gray, J. W., Shuman, M. A., and Chen, F. F. (2007) Paramagnetic silica-coated nanocrystals as an advanced MRI contrast agent J. Phys. Chem. C 111, 12542-12546
17. Rieter, W. J., Taylor, K. M. L., An, H., Lin, W., and Lin, W. (2006) Nanoscale metal-organic frameworks as potential multimodal contrast enhancing agents J. Am. Chem. Soc. 128, 9024-9029
18. Hifumi, H., Yamaoka, S., Tanimoto, A., Akatsu, T., Shindo, Y., Honda, A., Citterio, D., Oka, K., Kuribayashi, S., and Suzuki, K. (2009) Dextran coated gadolinium phosphate nanoparticles for magnetic resonance tumor imaging J. Mater. Chem. 19, 6393-6397
19. Hifumi, H., Yamaoka, S., Tanimoto, A., Citterio, D., and Suzuki, K. (2006) Gadolinium-based hybrid nanoparticles as a positive MR contrast agent J. Am. Chem. Soc. 128, 15090-15094
20. Fang, Y. P., Xu, A. W., Song, R. Q., Zhang, H. X., You, L. P., Yu, J. C., and Liu, H. Q. (2003) Systematic synthesis and characterization of single-crystal lanthanide orthophosphate nanowires J. Am. Chem. Soc. 125, 16025-16029
21. Lessing, P. A. and Erickson, A. W. (2003) Synthesis and characterization of gadolinium phosphate neutron absorber J. Eur. Ceramic Soc. 23, 3049-3054
22. Huang, Y.-F., Sefah, K., Bamrungsap, S., Chang, H.-T., and Tan, W. (2008) Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods Langmuir 24, 11860-11863
23. Medley, C. D., Smith, J. E., Tang, Z., Wu, Y., Bamrungsap, S., and Tan, W. (2008) Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells Anal. Chem. 80, 1067-1070
24. Villaraza, L. A. J., Bumb, A., and Brechbiel, M. W. (2010) Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics Chem. Rev. 110, 2921-2924
25. Cinier, M., Petit, M., Williams, M. N., Fabre, R. M., Pecorari, F., Talham, D. R., Bujoli, B., and Tellier, C. (2009) Bisphosphonate adaptors for specific protein binding on zirconium phosphonate-based microarrays Bioconjugate Chem. 20, 2270-2276
26. Lane, S., Monot, J., Petit, M., Bujoli, B., and Talham, D. (2007) XPS investigation of DNA binding to zirconium-phosphonate surfaces Colloid. Surf. B 58, 34-37
27. Monot, J., Petit, M., Lane, S. M., Guisle, I., Lager, J., Tellier, C., Talham, D. R., and Bujoli, B. (2008) Towards zirconium phosphonate-based microarrays for probing DNA-protein interactions: critical influence of the location of the probe anchoring groups J. Am. Chem. Soc. 130, 6243-6247
28. Hutton, C., Bork, A., Josephs, O., Deichmann, R., Ashburner, J., and Turner, R. (2002) Image distortion correction in fMRI: a quantitative evaluation NeuroImage 16, 217-240
29. Huo, Z. Y., Chen, C., Chu, D., Li, H. H., and Li, Y. D. (2007) Systematic synthesis of lanthanide phosphate nanocrystals Chem. Eur. J. 13, 7708
30. 4 Chem. Mater. 17, 822-826
31. Terreno, E., Castelli, D. D., Viale, A., and Aime, S. (2010) Challenges for molecular magnetic resonance imaging Chem. Rev. 110, 3019-3046
32. Wang, H., Yang, R., Yang, L., and Tan, W. (2009) Nucleic acid conjugated nanomaterials for enhanced molecular recognition ACS Nano 3, 2451-2460
33. Tang, Z., Parekh, P., Turner, P., Moyer, R. W., and Tan, W. (2009) Generating aptamers for recognition of virus-infected cells Clin. Chem. 55, 813-822